# stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]-pyrazole) — Federal controlled substance schedule (I-V) by drug, with DEA code number

For stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]-pyrazole), schedule is Schedule III; listed under is Anabolic steroids; cfr citation is 21 CFR 1308.13(f)(81), recorded from its source on 2026-09-01.

- **Substance:** stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]-pyrazole) _(verified: appears in the quote below)_
- **Schedule:** Schedule III _(verified: appears in its own passage below)_
- **Listed under:** Anabolic steroids _(verified: appears in its own passage below)_
- **CFR citation:** 21 CFR 1308.13(f)(81) _(our reading, not quoted from the source)_

## What the source says

> (81) stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]-pyrazole);

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Schedule

> § 1308.13 Schedule III.

### Listed under

> (f) Anabolic steroids.

## Source

- https://www.ecfr.gov/current/title-21/chapter-II/part-1308

Last verified: 2026-09-01. Review by: 2026-12-30.
Part of [Federal controlled substance schedule (I-V) by drug, with DEA code number](https://referencesource.org/dea-controlled-substance-schedule-by-drug/).